NIEVES
GONZÁLEZ GÓMEZ
Profesora asociada
Publicaciones (39) Publicaciones en las que ha participado algún/a investigador/a
2021
-
Whole-exome sequencing and C9orf72 analysis in primary progressive aphasia
Journal of Alzheimer's Disease, Vol. 80, Núm. 3, pp. 985-990
2019
-
Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction
Molecular Oncology, Vol. 13, Núm. 9, pp. 1887-1897
-
Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
Molecular Oncology, Vol. 13, Núm. 4, pp. 857-872
2018
-
Activation of bombesin receptor Subtype-3 by [D-Tyr 6 ,β-Ala 11 ,Phe 13 ,Nle 14 ]bombesin 6-14 increased glucose uptake and lipogenesis in human and rat adipocytes
Molecular and Cellular Endocrinology, Vol. 474, pp. 10-19
-
C-reactive protein expression in adipose tissue of children with acute appendicitis
Pediatric Research, Vol. 84, Núm. 4, pp. 564-567
-
Customized Dietary Intervention Avoids Unintentional Weight Loss and Modulates Circulating miRNAs Footprint in Huntington's Disease
Molecular Nutrition and Food Research, Vol. 62, Núm. 23
2017
-
2017 update on the relationship between diabetes and colorectal cancer: Epidemiology, potential molecular mechanisms and therapeutic implications
Oncotarget, Vol. 8, Núm. 11, pp. 18456-18485
-
Colon cancer modulation by a diabetic environment: A single institutional experience
PLoS ONE, Vol. 12, Núm. 3
-
Huntington's Disease and Diabetes: Chronological Sequence of its Association
Journal of Huntington's Disease, Vol. 6, Núm. 3, pp. 179-188
-
Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes
Cardiovascular Diabetology, Vol. 16, Núm. 1
2016
-
Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment
Pharmacological Research, Vol. 108, pp. 102-110
2015
-
Bombesin receptor subtype 3 as a potential target for obesity and diabetes
Expert Opinion on Therapeutic Targets, Vol. 19, Núm. 9, pp. 1153-1170
-
SecreEffect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes
International Journal of Molecular Medicine, Vol. 35, Núm. 4, pp. 925-931
2014
-
Human BRS-3 receptor: Functions/role in cell signaling pathways and glucose metabolism in obese or diabetic myocytes
Peptides, Vol. 51, pp. 91-99
2013
-
Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes
Molecular and Cellular Endocrinology, Vol. 367, Núm. 1-2, pp. 109-115
-
Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors
Journal of Pharmacology and Experimental Therapeutics, Vol. 347, Núm. 1, pp. 100-116
2012
-
Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states
Journal of Molecular Endocrinology, Vol. 48, Núm. 1, pp. 37-47
-
The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members
Biochemical Pharmacology, Vol. 84, Núm. 7, pp. 936-948
2011
-
Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state
Peptides, Vol. 32, Núm. 10, pp. 2077-2085
-
Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients
Regulatory Peptides, Vol. 168, Núm. 1-3, pp. 39-44